Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cowen & Co. Initiates Coverage On Xenon Pharmaceuticals with Outperform Rating

Cowen & Co. analyst Joseph Thome initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform rating.
byBenzinga Newsdesk
December 12, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Cowen & Co. analyst Joseph Thome initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0